home / stock / gern / gern news

GERN News and Press, Geron Corporation From 03/15/24

Stock Information
Company Name: Geron Corporation
Stock Symbol: GERN
Market: NASDAQ
Website: geron.com
Menu
GERN GERN Quote GERN Short GERN News GERN Articles GERN Message Board
Get GERN Alerts

News, Short Squeeze, Breakout and More Instantly...
GERN - Geron Corp. (NASDAQ: GERN) Near Top of Volume Charts in Friday Trading

Geron Corporation (NASDAQ: GERN) is one today's most active stocks by volume. So far today, approximately 40.37M shares of Geron Corporation have been exchanged, as compared to an average 30-day volume of 11.93M shares. Geron Corporation, a late-stage clinical biopharmaceutical company, focuse...
GERN - Geron surges after FDA AdCom backing for lead drug

2024-03-15 10:06:29 ET More on Geron Geron: Advisory Nod Boosts Approval Odds, But Market Position Remains Hazy Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA Geron Corporation (GERN) Q4 2023 Earnings Call Transcript Geron wins FDA...

GERN - Geron, Graphite Bio, Immuneering among healthcare movers

2024-03-15 10:00:13 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Johnson & Johnson, Boston...

GERN - US Companies Moving the Markets, Morning edition
Fri, Mar 15, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Grab Holdings Limited (GRAB) fell 0.2% to $3.235 on volume of 103,635,000 shares Better Therapeutics Inc. (BTTX) rose 108.6% to $0.073 on volume of 98,804,254 shares Verb Technology Company Inc. (VERB) rose 156.3% to $0.3639 on volume...
GERN - FDA ODAC Votes in Favor of Geron's Imetelstat Clinical Benefit/Risk Profile for the Treatment of certain Transfusion-Dependent Anemia Patients

2024-03-15 09:34:33 ET DENVER, Colo., Mar 15, 2024 ( 247marketnews.com )- Geron Corporation (NASDAQ: GERN ) announced that the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 12 to 2 in favor of the clinical benefit/risk profile of imetelstat, based on results from the ...

GERN - Geron: Advisory Nod Boosts Approval Odds, But Market Position Remains Hazy

2024-03-15 08:59:41 ET Summary Geron's valuation may overestimate imetelstat's market impact for MDS, given FDA's moderate enthusiasm and efficacy concerns. FDA concerns include imetelstat's marginal efficacy, safety issues, and a non-significant improvement in patient outcomes. ...

GERN - Biggest stock movers today: ADBE, GERN, and more

2024-03-15 05:45:23 ET More on related stocks: Adobe Inc. (ADBE) Q1 2024 Earnings Call Transcript Ulta Beauty, Inc. (ULTA) Q4 2023 Earnings Call Transcript Adobe Earnings: 3 Key Areas To Focus On With The Release Adobe in charts: Digital media revenue climbs ...
GERN - Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS

FDA Oncologic Drugs Advisory Committee voted 12 to 2 in favor of the clinical benefit/risk profile of imetelstat based on results from the IMerge Phase 3 clinical trial There are significant unmet needs across key TD LR-MDS patient populations, including difficult-to-treat subgroups that are ...

GERN - Geron wins FDA AdCom backing for blood cancer drug

2024-03-14 15:39:52 ET More on Geron Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA Geron Corporation (GERN) Q4 2023 Earnings Call Transcript Geron's Ideal Situation Appears To Be Already Priced In Geron slips as FDA reviews blood ...

GERN - Geron slips as FDA reviews blood cancer therapy ahead of AdCom meeting

2024-03-12 11:00:48 ET More on Geron Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA Geron Corporation (GERN) Q4 2023 Earnings Call Transcript Geron's Ideal Situation Appears To Be Already Priced In Seeking Alpha’s Quant Rati...
Previous 10 Next 10